Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-6.07%
operating margin TTM
-5.55%
revenue TTM
248.63 Million
revenue per share TTM
3.67$
valuation ratios | |
|---|---|
| pe ratio | -28.60 |
| peg ratio | 0.77 |
| price to book ratio | 2.20 |
| price to sales ratio | 1.83 |
| enterprise value multiple | 2,190.29 |
| price fair value | 2.20 |
profitability ratios | |
|---|---|
| gross profit margin | 86.74% |
| operating profit margin | -5.55% |
| pretax profit margin | -5.92% |
| net profit margin | -6.07% |
| return on assets | -4.08% |
| return on equity | -8.08% |
| return on capital employed | -4.6% |
liquidity ratio | |
|---|---|
| current ratio | 3.53 |
| quick ratio | 2.76 |
| cash ratio | 0.76 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 598.14 |
| operating cycle | 659.56 |
| days of payables outstanding | 698.21 |
| cash conversion cycle | -38.65 |
| receivables turnover | 5.94 |
| payables turnover | 0.52 |
| inventory turnover | 0.61 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.30 |
| debt equity ratio | 0.56 |
| long term debt to capitalization | 0.29 |
| total debt to capitalization | 0.36 |
| interest coverage | -2.02 |
| cash flow to debt ratio | -0.01 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.00 |
| cash per share | 0.27 |
| operating cash flow per share | -0.00 |
| free cash flow operating cash flow ratio | 2.06 |
| cash flow coverage ratios | -0.01 |
| short term coverage ratios | -0.28 |
| capital expenditure coverage ratio | -0.94 |
Frequently Asked Questions
When was the last time Pharming Group N.V. (NASDAQ:PHAR) reported earnings?
Pharming Group N.V. (PHAR) published its most recent earnings results on 30-09-2024.
What is Pharming Group N.V.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pharming Group N.V. (NASDAQ:PHAR)'s trailing twelve months ROE is -8.08%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pharming Group N.V. (PHAR) currently has a ROA of -4.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PHAR's net profit margin stand at?
PHAR reported a profit margin of -6.07% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PHAR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.53 in the most recent quarter. The quick ratio stood at 2.76, with a Debt/Eq ratio of 0.56.